Subarachnoid hemorrhage, cerebral ischemia and endothelin-1;Hemorragia subaracnoidea, isquemia cerebral y endotelina-1

Revista de Neurologia

Volumn 30, Issue 1, 2000, Pages 27-34

  Secades, J J ^a,b,c   Rubio, E ^a   Castellanos, J Ma ^a   De La Rosa, Ma D ^a   Mercadal, J ^b   Vilalta, J ^a   Catalan R ^a   Galard, R Ma ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

^c NONE   (Spain)

Author keywords

Cerebral vasospasm; Delayed ischemic neurological deficit; Endothelin 1; Pathophysiology; Subarachnoid hemorrhage

Indexed keywords

ENDOTHELIN 1;

AGED; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; BRAIN ISCHEMIA; BRAIN VASOSPASM; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLASGOW COMA SCALE; HUMAN; IMMUNOLOGY; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY; RISK FACTOR; SUBARACHNOID HEMORRHAGE;

AGED; ANTIBODY SPECIFICITY; BRAIN ISCHEMIA; ENDOTHELIN-1; FEMALE; GLASGOW COMA SCALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; VASOSPASM, INTRACRANIAL;

EID: 0033628541     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3001.99450     Document Type: Article

References (75)

1. Allen GS. Cerebral arterial spasm: a discussion of present and future research. Neurosurgery 1977; 1: 142-8.
2. Drake CG. Personal impressions. In Sano K, Takakura K, Kassell NF, Sasaki T, eds. Cerebral vasospasm. International Conference on Cerebral Vasospasm; 1990. Tokyo. Tokyo: University of Tokyo Press; 1990. p. 527-31.
3. Findlay JM, MacDonald RL, Weir BKA. Current concepts of pathophysiology and management of cerebral vasospasm following ancurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1991; 3: 336-61.
4. Kassell NF, Sasaki T, Colohan ART, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16: 562-72.
5. Smith RR. Pathophysiology and clinical evaluation of subarachnoid hemorrhage. Youmans JR, ed. Neurological surgery. Philadelphia: WB Saunders; 1982. p. 1627-44.
6. Spallone A. Cerebral vasospasm as a complication of aneurysmal subarachnoid hemorrhage: A brief review. Ital J Neurol Sci 1985; 6: 19-26.
7. Ebeling U, Reulen HJ. Cerebral vasospasm and aneurysm surgery. A review. Auer LM, ed. Timing of aneurysm surgery. Berlin: Walter de Gruyter; 1985. p. 411-20.
8. Wilkins RH. Cerebral vasospasm. Crit Rev Neurobiol 1990; 6: 51-77.
9. Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol 1983; 14: 599-608.
10. Morris KM, Shaw MDM, Foy PM. Ischemic deterioration following aneurysmal subarachnoid hemorrhage: definition by clinical criteria. Br J Neurosurg 1993; 7: 149-54.
11. Chyatte D, Sundt TM. Cerebral vasospasm after subarachrioid hemorrhage. Mayo Clin Proc 1984; 59: 498-505.
12. Cook DA. Mechanisms of cerebral vasospasm in subarachnoid hemorrhage. Pharmac Ther 1995; 66: 259-84.
13. Towart R. The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management. Acta Neurochir 1982; 63: 253-8.
14. Weir B. The pathophysiology of cerebral vasospasm. Br J Neurosurg 1995; 9: 375-90.
15. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-4.
16. Schini VB, Vanhoutte PM. Endothelin-I: a potent vasoactive peptide. Pharmacol Toxicol 1991; 69: 303-9.
17. Secades JJ, Lozano R, Novell R, Balaguer A. Endothelins and the central nervous system. Ann Psychiatr 1992; 3: 379-99.
18. Willette RN, Feuerstein GZ, Barone FC. Endothelin in the central nervous system. New Strategies to Prevent Neural Damage from Ischemic Stroke; 1994 Oct 27-28, Cambridge. Waltham (MA): Cambridge Healthtech Institute; 1994.
19. 2+ in subarachnoid hemorrhage-induced spasm of the rabbit basilar artery. Stroke 1996; 27: 1896-902.
20. th Meeting of the European Neurological Society; 1995 June 17-21, Munich.
21. Secades JJ. Papel de la endotelina 1 en la fisiopatología del vasoespasmo cerebral posthemorragia subaracnoidea. [Tesis doctoral]. Barcelona: Universidad Autónoma de Barcelona; 1998.
22. Alafaci C, Salpietro FM, Iacopino DG, Edvinsson L, Tomasello F. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm. Ital J Neurol Sci 1991; 12: 55-8.
23. Huneidi AHS, Thiemermann C, Lidbury PS, D'Orléans-Juste P, Änggard EE, Afshar F, et al. Endothelin-1 and big endothelin cause subarachnoid hemorrhage in the anesthetized rabbit. J Cardiovasc Pharmacol 1991; 17 (Suppl 7): S492-5.
24. Kobayashi H, Hayashi M, Kobayashi S, Kabuto M, Handa Y, Kawano H, et al. Cerebral vasospasm and vasoconstriction caused by endothelin. Neurosurgery 1991; 28: 673-9.
25. Nakagomi T, Yamakawa K, Ide K, Sasaki T, Saito I, Takakura K. Role of endothelin-1 in experimental cerebral vasospasm. In Sano K, Takakura K, Kassell NF, Sasaki T, eds. Cerebral vasospasm. International Conference on Cerebral Vasospasm; 1990, Tokyo. Tokyo: University of Tokyo Press; 1990. p. 242-5.
26. Papadopoulos SM, Gilbert LL, Webb RC, D'Amato CJ. Characterization of contractile responses to endothelin in human cerebral arteries: Implications for cerebral vasospasm. Neurosurgery 1990: 26: 810-5.
27. Sasaki T, Itoh S, Nishikibe M. Recent advances in research of cerebral vasospasm. Possible participation of endothelin in the genesis of vasospasm. In Pasqualin A, Da Pian P. eds. New trends in management of cerebro-vascular malformations. Wien: Springer-Verlag; 1994. p. 32-7.
28. Takenaka K, Yamada H, Sakai N, Ando T, Nakashima T, Nishimura Y. Induction of cytosolic free calcium elevation in rat vascular smooth-muscle cells by cerebrospinal fluid from patients after subarachnoid hemorrhage. J Neurosurg 1991; 75: 452-7.
29. Yamaura I, Tani E, Maeda Y, Minami N, Shindo H. Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 1992; 76: 99-105.
30. B receptors in subarachnoid hemorrhage-induced cerebral vasospasm. Eur J Pharmacol 1994; 259: R1-2.
31. Zuccarello M, Romano A, Passalacqua M, Rapoport RM. Endothelin-1-induced endothelin-1 release causes cerebral vasospasm in vivo. J Pharm Pharmacol 1995; 47: 702.
32. Mima T, Yanagisawa M, Shigeno T, Saito A, Goto K, Takakura K, et al. Endothelin acts in feline and canine cerebral arteries from the adventitial side. Stroke 1989; 20: 1553-6.
33. Shigeno T, Mima T, Takakura K, Yanagisawa M, Saito A, Goto K, et al. Endothelin-1 acts in cerebral arteries from the adventitial but not from the luminal side. J Cardiovasc Pharmacol 1989; 13 (Suppl 5): S174-6.
34. Yang Z, Richard V, Von Segesser L, Bauer E, Stulz P, Turina M, et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: A new mechanism of vasospasm? Circulation 1990; 82: 188-95.
35. Kobayashi M, Nishikibe M, Maruyama H, Yano M, Ikemoto F, Ide K, et al. Localization and alteration of immunoreactive endothelin-1 in canine basilar arteries following subarachnoid hemorrhage. Acta Histochem Cytochem 1995; 28: 129-36.
36. Alafaci C, Jansen I, Arbab AR, Shiokawa Y, Svendgaard NA, Edvinsson L. Enhanced vasoconstrictor effect of endothelin in cerebral arteries from rats with subarachnoid hemorrhage. Acta Physiol Scand 1990; 138: 317-9.
37. Alafaci C, Jansen I, Svendgaard NA, Edvinsson L. Endothelin-induced vasoconstriction of cerebral arteries is enhanced in rats with subarachnoid hemorrhage. In Sano K, Takakura K, Kassell NF, Sasaki T, eds. Cerebral vasospasm. International Conference on Cerebral Vasospasm; 1990, Tokyo. Tokyo: University of Tokyo Press; 1990. p. 246-9.
38. Kamata K, Nishiyama H, Miyata N, Kasuya Y. Changes in responsiveness of the canine basilar artery to endothelin-1 after subarachnoid hemorrhage. Life Sci 1991; 49: 217-24.
39. Tanoi C, Suzuki Y, Shibuya M, Sugita K, Masuzawa K, Asano M. Mechanism of the enhanced vasoconstrictor responses to endothelin-1 in canine cerebral arteries. J Cereb Blood Flow Metab 1991 ; 11: 371-9.
40. Wang XY, Zhu C, Zhang GJ, Lu YC. Changes of endothelin during cerebral vasospasm after experimental subarachnoid hemorrhage. Chin Med J 1995; 108: 586-90.
41. Cocks TM, Malta E, King SJ, Woods RL, Angus JA. Oxyhemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 1991; 196: 177-82.
42. Kasuya H, Weir BKA, White DM, Stefansson K. Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg 1993; 79: 892-8.
43. Machi T, Stewart D, Kassell NF, Comair Y, Nihei H, Tanaka Y. Hemoglobin enhances release of endothelin from cultured bovine endothelial cells. In Sano K, Takakura K, Kassell NF, Sasaki T, eds. Cerebral vasospasm. International Conference on Cerebral Vasospasm; 1990, Tokyo. Tokyo: University of Tokyo Press; 1990. p. 262-5.
44. Ohlstein EH, Storer BL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 1992; 77: 274-8.
45. Barone FC, Globus MYT, Price WJ, White RF, Storer BL, Feuerstein GZ, et al. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 1994; 14: 337-42.
46. Viossat I, Duverger D, Chapelat M, Pirotzky E, Chabrier PE, Braquet P. Elevated tissue endothelin content during focal cerebral ischemia in the rat. J Cardiovasc Pharmacol 1993; 22 (Suppl 8): S306-9.
47. Matsumura Y, Ikegawa R, Suzuki Y, Takaoka M, Uchida Y, Kido H, et al. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in cerebrospinal fluid. Life Sci 1991; 49: 841-8.
48. Caner HH, Kwan AL, Arthur A, Jeng AY, Lappe RW, Kassell NF, et al. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg 1996; 85: 917-22.
49. A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 1993; 195: 969-75.
50. Foley PL, Caner HH, Kassell NF, Lee KS. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 1994; 34: 108-13.
51. Hino A, Weir BKA, MacDonald RL, Thisted RA, Kim CJ, Johns LM. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 1995; 83: 503-9.
52. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal, but not intravenous injection. Life Sci 1993; 52: 825-34.
53. Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 1994; 25: 2450-6.
54. Shigeno T, Clozel M, Sakai S, Saito A, Goto K. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery 1995; 37: 87-91.
55. Zimmermann M, Seifert V, Löffler BM, Stolke D, Stenzel W. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Neurosurgery 1996; 38: 115-20.
56. Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg 1996; 84: 503-7.
57. Onoda K, Ono S, Ogihara K, ShiotaT, Asari S, Ohmoto T, et al. Inhibition of vascular contraction by intracistemal administration of prepro-endothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 1996; 85: 846-52.
58. Secades JJ, Rubio E, de la Rosa MD, Castellanos JM, Catalán R, Andreu JR. Endothelin receptor antagonists. Ann Psychiatr 1996; 6: 293-308.
59. Battistini B, D'Orléans-Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993; 68: 600-28.
60. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K. Raised plasma endothelin in aneurysmal subarachnoid hemorrhage. Lancet 1989; ii: 1402.
61. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K. Raised plasma and cerebrospinal fluid endothelin in aneurysmal subarachnoid hemorrhage. In Sano K, Takakura K, Kassell NF, Sasaki T, eds. Cerebral vasospasm. International Conference on Cerebral Vasospasm; 1990, Tokyo. Tokyo: University of Tokyo Press; 1990. p. 266-8.
62. Fujimori A, Yanagisawa M, Saito A, Goto K, Masaki T, Mima T, et al. Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Lancet 1990; 336: 633.
63. th Meeting of European Neurological Society; 1994 June 24-30, Barcelona.
64. Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K. The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1992; 77: 96-100.
65. Shirakami G, Magaribuchi T, Shingu K, Kim S, Saito Y, Nakao K, et al. Changes of endothelin concentration in cerebrospinal fluid and plasma of patients with aneurysmal subarachnoid hemorrhage. Acta Anesthesiol Scand 1994; 38: 457-61.
66. Seifert V, Löffler BM, Zimmermann M, Roux S, Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 1995; 82: 55-62.
67. Ehrenreich H, Lange N, Near KA, Anneser F, Schoeller LAC, Schmid R, et al. Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med 1992; 192: 257-68.
68. Suzuki H, Sato S, Suzuki Y, Oka M, Tsuchiya T, lino I, et al. Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid hemorrhage. Ann Med 1990; 22: 233-6.
69. Suzuki H, Sato S, Suzuki Y, Takekoshi K, Ishihara N, Shimoda S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 1990; 81: 553-4.
70. Sato S, Ishihara N, Yunoki K, Nakamigawa T, Oohira T, Takayama H, et al. The changes of endothelin concentration in CSF following subarachnoid hemorrhage. In Sano K, Takakura K, Kassell NF, Sasaki T, eds. Cerebral vasospasm. International Conference on Cerebral Vasospasm; 1990, Tokyo. Tokyo: University of Tokyo Press; 1990. p. 269-71.
71. Kraus GE, Bucholz RD, Yoon KW, Knuepfer MM, Smith KR. Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: A clinical study and literature review. Surg Neurol 1991; 35: 20-9.
72. Gaetani P, Rodriguez y Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P. Endothelin and aneurysmal subarachnoid hemorrhage: a study of subarachnoid cistemal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1994; 57: 66-72.
73. Gaetani P, Grignani G, Spanu G, Rodriguez y Baena R. A study on cisternal CSF levels of endothelin-1 after subarachnoid hemorrhage. In Pasqualin A, Da Pian R, eds. New trends in management of cerebro-vascular malformations. Wien: Springer-Verlag; 1994. p. 43-7.
74. Hamann G, Isenberg E, Strittmatter M, Schimrigk K. Absence of elevation of big endothelin in subarachnoid hemorrhage. Stroke 1993; 24: 383-6.
75. Shigeno T, Mima T, Takakura K, Yanagisawa M, Saito A, Fujimori A, et al. Role of endothelin in cerebral vasospasm. In Sano K, Takakura K, Kassell NF, Sasaki T, eds. Cerebral vasospasm. International Conference on Cerebral Vasospasm; 1990, Tokyo. Tokyo: University of Tokyo Press; 1990. p. 250-2.